13Oct

Abingdon Health Ltd (“Abingdon”) has announced its entry in the UK Parliamentary Review 2017 (“The Review”) has now been published.

While focusing on 12 key government policy areas, the Review, which is distributed to Policymakers in the UK and abroad, allows leading organisations and executives to share personal insight as well as discuss good practice alongside Cabinet and senior ministers.

Abingdon, whose core expertise lies in the development and manufacturing of immunoassay tests and reader systems, has been chosen to represent the rapid diagnostics testing industry.

Abingdon Health is included within the 2016/2017 Healthcare Parliamentary Review which includes Forwards from The Right Honourable Theresa May MP, Prime Minister, Luciana Berg MP, Member of the Health Select Committee and Niall Dickson, Chief Executive of the NHS Confederation.

In the Review, Abingdon Health Chief Executive Office, Chris Yates, offers insight into the growth of the diagnostics industry, outlines Abingdon’s strategy as well discusses the factors he believes have driven the success of Abingdon to date, including a focus on building an open, collaborative culture, investment in automation and innovation and a continual focus on quality improvement.

To read Abingdon Health’s entry in the Parliamentary Review 2017 (pages 32 – 34) visit https://www.theparliamentaryreview.co.uk/editions/healthcare/healthcare

Related

BBI Solutions wins Dx Creative Award for Morffi™ launch

BBI Solutions is pleased to announce that it has triumphed at the DxMA’s 2017 Dx Creative Awards, w...

Read More >

Evaluation studies confirm improved oncology patient pathways through HORIBA Medical’s new POC haematology analyser

Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-b...

Read More >

DEMAND FOR GENETIC TESTING DRIVES GROWTH FOR AWARD WINNING ELUCIGENE DIAGNOSTICS

30 percent growth and innovation products wins Manchester company BVCA award. Having the right te...

Read More >

BBI Solutions & Dr C. Sturgeon consider International Standards for Cancer Biomarkers

Dr Catharine Sturgeon will be presenting her case for an international effort to align manufacturer’...

Read More >

Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer's Disease

8th May 2018: Oxford & Manchester, UK and Atlanta, GA. Cytox, a precision medicine testing company ...

Read More >

EKF to highlight Lucica® Glycated Albumin-L assay for diabetes patient monitoring at AACC 2019

Specific, intermediate glycemic control marker for diabetes at EKF’s Booth #2952 at AACC 2019 Clini...

Read More >